Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — New Study Suggests CBD Could Reduce Consumption of Alcohol

Cannabidiol (“CBD”) is one of more than 100 chemical compounds called cannabinoids, which are produced in the cannabis family. You’ve probably heard of THC (delta-9 tetrahydrocannabinol), the main psychoactive component responsible for cannabis’ intoxicating effects. CBD, on the other hand, is not psychoactive, although studies have found that this cannabinoid is capable of alleviating a variety of medical conditions. While the research behind CBD’s medical claims is limited, initial results have been quite promising, which has led to increased scientific interest in CBD’s abilities.

One of the more recent studies has uncovered something that could have wide-ranging implications for millions of people: CBD may have the ability to reduce alcohol consumption. Despite the substances being portrayed as a terrible drug for decades, a new study has found that cannabidiol is up to 114 times safer than alcohol, meaning users are more than 114 times more likely to overdose on alcohol than cannabidiol. Researchers studied the risks of consuming several different substances, including alcohol, nicotine, cocaine, heroin, ecstasy and CBD, and they found that cannabidiol has a significantly lower associated risk compared to the other substances

In fact, CBD was the only drug classified as low risk, while alcohol was classified as a high-risk substance alongside nicotine, heroin and cocaine. Alcohol was considered especially high risk as it is legal, widely accessible and barely has any stigma attached to it, unlike hard drugs such as cocaine and heroin. The report, which was published in “Scientific Reports Journal,” said that many countries underestimated alcohol’s inherent risks while overestimating cannabis’ negative effects, and this guided the drug policies the study adopted.

Another recent study found that not only is CBD much safer than alcohol, but that it also can be used to curb alcohol cravings. While exploring the relationship between CBD and alcohol, researchers found that it could have led to reduced alcohol consumption among regular cannabis users. The authors of the study suggested that switching to low-THC, high-CBD cannabis strains could be beneficial for individuals looking to reduce their alcohol intake.

Researchers gave 120 participants who used both cannabis and alcohol three different cannabis strains: a THC-dominant one, a CBD-dominant one, and a strain with both CBD and THC. At the end of the study, they found that the group with the CBD-dominant cannabis strain had fewer alcohol use days as well as fewer CBD and alcohol co-use days. This provides evidence against the theory that cannabis use lends itself to alcohol use, although more research will be needed before these results are conclusive.

This research adds to the growing body of evidence in support of the various medical cannabis products manufactured by sector players such as Sonoma Biologics Corp. and the industry in general.

NOTE TO INVESTORS: The latest news and updates relating to Sonoma Biologics Corp. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Inks Deal with Top U.S. Inventory, Fulfillment Technology Provider

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, this morning announced that it has signed a partnership with an award-winning U.S. inventory and fulfillment technology platform provider. With hundreds of professionally operated fulfillment centers strategically situated throughout the United States, the partnership provides BevCanna access to a reliable fulfillment platform as well as two-day shipping anywhere in the country. “We’re pleased to be able to leverage this unique logistics systems in the U.S. launch of our TRACE line of products,” BevCanna Enterprises President Melise Panetta stated in the news release. “Employing this sophisticated cloud-based platform will allow us to accelerate our launch across the country and ensure seamless delivery of our TRACE products to retailers nation-wide.”

To view the full press release, visit https://cnw.fm/ISz9l

About BevCanna Enterprises Inc.

BevCanna Enterprises Inc. is a diversified health & wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based, and cannabinoid beverages and supplements for both in-house brands and white-label clients.

With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands. For more information, visit the company’s website at www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — A Brief Analysis of Colorado’s Cannabis Tax Revenue

In the year 2012, voters in the state of Colorado legalized adult-use cannabis and approved Amendment 64, which made it the first state in the country to have a legal recreational cannabis market.

Since then, Colorado has made more than $10 billion in total cannabis sales. In 2020, while other industries suffered at the hands of the coronavirus pandemic, cannabis sales increased significantly in the state.

In January this year, cannabis sales topped $180 million, which set a new record. In the last six years, the state has collected more than $1.5 billion in fee revenues and cannabis taxes. This revenue stream was a key selling point for voters in the state when the legalization measure was being passed in 2012. Many are curious to know how these monies have been allocated.

According to Amendment 64, the state is obligated to collect a 15% special sales tax when marijuana changes possession from cultivator to seller and a 2.9% sales tax from both recreational and medical sales. The 2.9% tax on medical cannabis is directed to the Marijuana Tax Cash Fund.

The amendment also has a clause that states that 90%, or the first $40 million, accumulated is to be allocated to a capital construction grant program, where different education providers, districts and schools can apply for funds to renovate existing facilities or construct new buildings.

On the other hand, the 15% excise tax is directed to the general fund of the state of Colorado, with a portion being allocated to the State Public School Fund, which is managed by the Department of Education. The remaining amount is allocated to the Marijuana Tax Cash Fund.

Since legal retail sales began in 2012, more than 15% of the budget of the Marijuana Tax Cash Fund has been directed to education initiatives. However, while cannabis tax dollars help fund construction and school maintenance, they don’t address per pupil funding, with very little of these taxes being directed to school operating budgets for school supplies, books and teacher salaries.

In addition, different jurisdictions in the state allocate cannabis tax revenues differently. For instance, in the period between 2014-2019, Denver allocated more than $15 million to youth prevention with more than $25 million in tax dollars also going to cannabis enforcement and regulation. Additionally, $19 million, over $3 million and more than $15 million was allocated to city capital improvements, opioid intervention and affordable housing respectively.

Legislators in the state are being pushed to change how tax revenue is used annually and introduce legislations to establish new programs.

While a lot of attention may be directed towards the tax benefits of the cannabis sector, it is also worthwhile to be cognizant of the work done by companies such as RYAH Group Inc. (CSE: RYAH), which is developing cutting-edge IoT dose-measuring devices with the potential to take plant medicine (medical cannabis, for example) to a whole new level of precision.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Cannabis Prohibition Costs $53 Billion Annually in the US

When it was first initiated, the war on drugs had relatively noble goals: to eliminate the production, distribution, and consumption of psychoactive drugs, consequently reducing the number of people addicted to these drugs and stripping the criminal enterprises behind the drug trade of their resources. However, decades after former President Nixon declared the infamous war on drugs, the drug war is considered an unmitigated failure by most. Not only has it failed to curb drug use in the country and barely put a dent in the illicit drug trade, but it also has sent countless millions to prison for relatively tame offenses such as drug possession and cost the United States billions of dollars.

According to a report published on AmericanMarijuana.org, the United States loses a whopping $53 billion every year to cannabis prohibition. Most of this money goes towards cannabis arrests, prosecutions, and incarceration, with most of these individuals having done nothing more than possess small amounts of cannabis. As the country’s economy tries to shrug off the catastrophic effects of the coronavirus pandemic and the subsequent lockdowns, cannabis reform advocates argue that this money, which is mostly funded by taxpayers, could be dedicated to much better causes.

Over the past decade, more and more states have legalized cannabis for either recreational or medical use, culminating in a lucrative state-legal cannabis industry that has employed thousands of individuals across the country and provided billions of dollars in tax revenue. However, cannabis remains illegal at the federal level, meaning that the businesses and people that participate in the state-legal cannabis sector are always at risk of suffering federal repercussions.

This prohibition has undoubtedly ruined millions of lives. Not only does prosecution and incarceration negatively affect the individual’s family and the community at large, but having a criminal record also hinders an individual’s ability to seek gainful employment and obtain student loans, a driver’s license, and even housing. Once a cannabis offense blemishes your record, your chances of surviving and thriving in the increasingly capitalist America are greatly reduced.

More than that, the war on drugs has been a war on people, and as House Majority Leader Chuck Schumer says, it has often been a war on people of color. Research has found that individuals of color are much more likely to be arrested for marijuana-related offenses compared to white individuals despite similar usage rates. After decades of intense policing and harsh sentencing, these communities have been left broken and beaten down.

Thus, support for cannabis reform has been growing steadily, especially among lawmakers. Schumer has been working on a Senate version of a cannabis legalization bill with Senators Ron Wyden and Cory Baker while House Judiciary Chairman Jerrold Nadler plans to reintroduce his historic Marijuana Opportunity, Reinvestment, and Expungement (“MORE”) Act as soon as this week.

When lawmakers eventually ease the federal restrictions on cannabis, the work of companies like XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), which is engaged in developing cannabis-based medications, will be eased somewhat since the current regulatory barriers cost lots of time and other resources to navigate.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Completes Pre-Qualification for Entry into Michigan Market

Red White & Blo o m Brands (CSE: RWB) (OTCQX: RWBYF) today announced that it has completed the more comprehensive portion of Michigan’s two-step application process for marijuana licensing through a wholly owned operating subsidiary, RWB Michigan LLC. The Marijuana Regulatory Agency (“MRA”) pre-qualification represents authorization of the company to proceed with its full operational strategy in the state and complete the licensing process for its intended facilities. All application materials, background checks and payment of the application fees have been completed as part of the first step, which is pre-qualification. “Michigan has been one of the highest bars of entry to any market we’ve entered. The regulatory body has done it right and all stakeholders should feel comfort with the level of scrutiny and governance we have to be compliant with as operators. This now provides a path for us to fully execute on our strategy of being the house of brands and being great channel partners to all of our distribution points as well as our own planned flagship retail locations,” said RWB CEO and Chairman Brad Rogers. “Entering Michigan provides RWB access to a market with a population of approximately 10 million people, and one where recent state monthly sales are over US$145 million. Given the number of documents and rigorous background check process, pre-qualification is the most significant regulatory hurdle in the Michigan marijuana licensing process.”

To view the full press release, visit https://cnw.fm/fXce5

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona, and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Secures Purchase Order from British Columbia LDB

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, today announced that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., through its distribution partner, has received an initial purchase order for its edible cannabis gummies from the British Columbia Liquor Distribution Branch (“LDB”). Demand for Pure Extracts’ Pure Chews branded THC and CBD gummies is strong within the provincial markets, where the company anticipates that Fire Burst, like its U.S. counterpart, will be one of the top selling gummies. “The edible gummie business is a material revenue producer for Pure Extracts,” said CEO Ben Nikolaevsky. “We are excited to have received our first purchase order for Fire Burst cinnamon flavored gummies from the wholesaler serving our home province of British Columbia, the LDB, adding them to our provincial distribution and look forward to a successful long-term relationship that leads to a satisfied customer base. With our proprietary manufacturing and packaging machine and our high-quality cannabis extracts, we have created the type of exceptional gummie products that consumers now demand.”

To view the full press release, visit https://cnw.fm/FEusG

About Pure Extracts Technologies Corp.

Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Health Canada, under the Cannabis Act, granted Pure Extracts its Standard Processing License on Sept. 25, 2020. The company’s stock began trading on the Canadian Securities Exchange (“CSE”) on Nov. 5, 2020. For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://cnw.fm/PULL

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — Jerrold Nadler Could File Revised MORE Act ‘Very Soon’

For the past couple of years, the cannabis industry in the United States has been slowly but surely gathering steam. More than 30 states have legalized marijuana for either medical or recreational use, with the state-legal cannabis industry employing thousands of Americans and providing states with millions of dollars in much-needed tax revenue. However, cannabis advocates have always had their eyes on legislation that would decriminalize the controversial drug at the federal level, and with Democrats controlling the Senate, House and White House, their dream may soon become a reality.

According to Marijuana Moment, a key chairperson may be planning to reintroduce a bill that would legalize cannabis at the federal level as well as promote social equity in the House as early as this week. This version of the legislation will contain at least two major changes compared to the previous version.

Jerrold Nadler, the House Judiciary Committee chair sponsored the Marijuana Opportunity, Reinvestment, and Expungement (“MORE”) Act, a bill that would federally deschedule marijuana and expunge the records of individuals with prior cannabis convictions. The bill cleared the House late last year in a historic vote, although it stood little chance in the then Republican-controlled Senate and failed to advance.

However, sources close to the issue say the MORE Act may be refiled as soon as this week with Nadler planning to introduce the revised legislation before Congress breaks for Memorial Day recess. A provision that was added before the House floor vote in December that would have prevented individuals with prior cannabis convictions from opening and running cannabis businesses will not be included. This version of the legislation will have significant social equity provisions as well as language that extends to the Small Business Administration (“SBA”), providing individuals with loans, job training, and financial literacy programs, among others.

Consequently, individuals from communities that were unjustly persecuted due to the decades-long war on drugs will be able to conduct business in other industries, not just the nascent cannabis sector. The United States has treated cannabis as a criminal matter rather than a public health issue, Nadler said two months ago when he first announced that he intended to reintroduce the MORE Act. Not only have communities of color been victims of cannabis arrests, prosecutions, and incarceration at a higher rate when compared to their white counterparts, he said, but anti-cannabis policies have also cost the country quite a lot.

Over in the Senate, Majority Leader Chuck Schumer, Senator Cory Booker and Senate Finance Chairman Ron Wyden have been working on a cannabis reform bill that will be introduced to the Senate soon.

If this bill is eventually passed into law, the entire cannabis sector, including actors such as Gage Growth Corp. (CSE: GAGE) (d.b.a. Gage Cannabis), will be relieved that the regulatory complications they face are becoming streamlined.

NOTE TO INVESTORS: The latest news and updates relating to Gage Growth Corp. (CSE: GAGE) (d.b.a. Gage Cannabis) are available in the company’s newsroom at https://cnw.fm/GAGE

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study to Survey Health-Care Workers, Obtain Input on Medical Marijuana

A study that will involve acquiring input on healthcare workers’ experience with medical marijuana and advice on the same was recently announced. The study, which will involve experts from the University of Massachusetts’ Dartmouth Charlton College of Business, Medicinal Genomics and the Cannabis Center of Excellence Inc. (“CCOE”) will focus on health-care workers in both Canada and the United States.

The study will gather information on the experiences of health-care providers with medical marijuana in their practices and the interest they may have in future clinical education associated with medical marijuana.

Cannabis Center of Excellence Inc. president Dr. Marion McNabb highlighted that approaches to incorporate medical marijuana use, along with knowledge of the risks and benefits of medical marijuana and the endocannabinoid system’s basics weren’t part of the regular curriculum for the majority of the health professionals. This includes those in emergency medicine, addiction and recovery, public health, dental, nursing and medical.

As more evidence on the effectiveness of marijuana is unearthed, the study’s objective is to hear from health-care providers on how the use of marijuana can be incorporated into their practices. In addition to this, the study will also focus on what health-care providers want to know about medical marijuana and what they do know.

A study that was published in 2019 discovered that more than 58% of health-care providers were of the opinion that medical marijuana was a legitimate medical therapy. The authors of the study noted that for provider concerns to be addressed, accurate information on the potential for drug interactions needed to be spread.

A separate study noted that standardized education would make sure that health-care providers were prepared to promote the responsible use of marijuana if it had been indicated for medically appropriate conditions and symptoms.

Despite the advances made though, more is still required. Earlier in April, a study conducted in Israel found that Israeli medical students felt unprepared despite the fact that they were more supportive of the use of medical marijuana to manage pain, in comparison with their counterparts in Thailand.

The CCOE also revealed that the study, which is backed by the Super Critical Labs, has been approved for human research by the Dartmouth Institutional Review Board. It also noted that the anonymous survey, which would be available from May 2021 to May 2022, would take roughly 12 minutes for health-care providers to complete.

McNabb, who is the chief investigator, will be joined by 15 other researchers, including veterans, clinicians and other scientists. The body expects that initial study results will be available by October 2021.

As a growing amount of more marijuana research is done by independent entities, the products made by sector players such as Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are likely to gain more acceptance from the medical community since the products will be better understood by that segment.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Releases Q1 2021 Financial Numbers, Chooses SRAX Inc. (NASDAQ: SRAX) as Communications Partner

Grapefruit USA (OTCQB: GPFT), a California-based cannabis company, has partnered with SRAX Inc. (NASDAQ: SRAX), an investor relations and communications marketing firm, to strengthen its brand and product line as well as increase awareness of its new e-commerce site and related affiliate program. In the announcement Grapefruit cited SRAX’s novel data-driven approaches to marketing and the company ability to create awareness of stock as key factors in its decision. In addition, the company has filed its quarterly report for the period ended March 31, 2021. The report included disappointing numbers for the company, including net revenues of $350,815, a decrease of 10% over revenues of $393,559 for the three months ended March 31, 2020. In the announcement, the company pointed to a strong cannabis harvest in fourth-quarter 2020 and early 2021 cannabis as a contributing factor behind the reduction in revenues, noting that the harvest drove down wholesale cannabis prices and limited the profitability of GPFT’s distribution and trading operations. As a result, Grapefruit limited distribution and trading efforts, focusing more on improving upon and launching its Hourglass products. The company anticipates those efforts will result in significantly higher Hourglass-related revenues through the remaining quarters of 2021 and into 2022. GPFT also expects is newly launched ecommerce site and affiliate program to fuel the company’s revenues moving forward. “We are obviously dissatisfied with the small revenue decrease year over year for the first quarter,” said Grapefruit CEO Bradley J. Yourist in the press release. “However, we adjusted by decreasing our less-profitable distribution and trading activities, which we can switch on at a moment’s notice when the seasonal aspect of the wholesale cannabis business adjusts, and profitable distribution and trading opportunities present themselves during the remainder of the year as they inevitably do. Furthermore, as our wholesale and retail Hourglass THC/cannabinoid and THC-free hemp derived CBD products sales take off in the remainder of 2021 and beyond, the increased revenues they generate will mitigate the overall revenue impact of the seasonality of the distribution and trading operations. Getting to that point as quickly as possible is one of our primary goals, and as we always do, we will attain it in the near future.”

To view the full press releases, visit https://cnw.fm/nwdXd and https://cnw.fm/cfWU9

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Missouri Court Rules That Medical Cannabis License Applications Aren’t Secret

Medical marijuana license applicants in Missouri were offered a much-needed reprieve after an appeals court ruled that state regulators cannot keep information from medical cannabis applications secret. In 2018, voters approved a constitutional amendment that legalized medical marijuana, making Missouri the 33rd state to legalize medical cannabis. Soon after, hundreds of business owners who saw a solid business opportunity applied for business licenses for everything from growing and distributing to selling cannabis, and chaos soon ensued.

More than 820 companies were denied licenses. Those companies asked an administrative hearing commission to look into the scoring system used to score candidates, claiming that it was flawed and unfair. Health and Senior Services (“DHSS”), which was tasked with overseeing the license application process, scored more than 1,700 candidates, ultimately awarding state licenses to 60 cultivators, 86 infused manufacturers, 11 testing facilities, 192 dispensaries and 22 transporters.

Consequently, Kings Garden Midwest, a California-based company that had sought and failed to acquire a cannabis cultivation license, filed a lawsuit against the state claiming that the scoring process used to grade applicants was “arbitrary and capricious.” Applicants would be awarded different points for the same or similar answers, and Kings Garden wanted to go over the information on other applications to see if the scoring was actually fair. The court agreed with Kings Garden, stating in a precedent-setting ruling that the information on application licenses could not be kept secret.

Since applications are ranked competitively against each other rather than solely on their own merits, the court wrote, comparing the information in these applications was the only way to find out if the Kings Garden’s application was scored in an “arbitrary or capricious manner.” According to the court, keeping this information from companies seeking to prove whether or not the scoring system was flawed is “unreasonable and absurd.” However, the DHSS, which outsourced the application scoring process to a private company, argued that the constitutional amendment that legalized medical marijuana in the state requires that such information remains confidential.

Lisa Cox, a DHSS spokesperson, says that the department is planning on appealing the ruling at the Supreme Court. Missouri’s licensing process has been upheld by numerous legal challenges, and Greg Wu, co-chair of cannabis law practice group Hardy & Bacon law states that the state will see quite a number of lawsuits regarding medical marijuana applications. Lyndall Frankel, the DHSS’ top cannabis regulator, says that the health department expects to spend at least $12.4 million fighting these suits.

The campaign to accord the cannabis industry equal treatment is likely to notch a win if the DHSS loses its planned appeal to the state Supreme Court. If that happens, the entire sector, including companies such as Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd. (CSE: CHAL) (OTCQB: GLDFF), could regard that as just another step forward, and the push for an improved operational environment for the industry will continue.

NOTE TO INVESTORS: The latest news and updates relating to Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd. (CSE: CHAL) (OTCQB: GLDFF), are available in the company’s newsroom at https://cnw.fm/GLDFF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.